ILMN Illumina
- 122.280
- +1.230+1.02%
- 123.690
- +1.410+1.15%
Illumina News
Pillar Biosciences OncoReveal CDx Pan-cancer Solid Tumor IVD Now FDA Approved for General Tumor Profiling on the Illumina MiSeq Dx System
Company continues to execute on its global strategy to bring highly accurate and sensitive NGS cancer diagnostics to enable localized testingNATICK, Mass., April 23, 2024 /PRNewswire/ -- Pillar Biosc
Illumina (NASDAQ:ILMN) Investors Are Sitting on a Loss of 71% If They Invested Three Years Ago
Express News | Illumina Inc : Bernstein Cuts Target Price to $129 From $150
Top High Growth Investment Ratio Stocks From Each Sector - GS
Illumina, Inc.'s (NASDAQ:ILMN) Share Price Not Quite Adding Up
Illumina, Inc.'s (NASDAQ:ILMN) price-to-sales (or "P/S") ratio of 4.2x may not look like an appealing investment opportunity when you consider close to half the companies in the Life Sciences industry
Express News | Illumina Inc : HSBC Cuts Target Price to $130 From $140: HSBC Cuts Target Price to $130 From $140
Engineering a Cool Career in Biotech - and Volunteering Along the Way
What kind of opportunities can an engineer find through their work? Plenty, at Illumina! One employee shares how she makes a difference.Originally published on Illumina News Center NORTHAMPTON, MA / A
Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
The Medical Genome Initiative presents a paper in an effort to expand patient access to sequencingOriginally published on Illumina News CenterNORTHAMPTON, MA / ACCESSWIRE / April 17, 2024 / A recent l
Unusual Options Activity: ETRN, ILMN and Others Attract Market Bets, ETRN V/OI Ratio Reaches 294.1
EST Apr 16th Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
Looking Into Illumina's Recent Short Interest
Illumina's (NYSE:ILMN) short percent of float has risen 5.16% since its last report. The company recently reported that it has 5.21 million shares sold short, which is 3.67% of all regular shares that
Stocks With the Least Price Swings, Most Attractive Option-sale Candidates - JPM
Express News | Illumina’s Planned Divestment of Grail Approved by the European Commission
Express News | Illumina: in Event of Capital Markets Transaction, Co Must Capitalize Grail With 2-1/2 Years of Funding, Which Is Estimated at About $1 Bln
Express News | Illumina: Continues to Explore Divesting Grail Through Either Trade Sale or Capital Markets Transaction
Leerink Partners Adjusts Illumina's Price Target to $155 From $170
Leerink Partners Adjusts Illumina's Price Target to $155 From $170.
Express News | EU Approved Illumina's Plan To Divest Grail
Express News | EU Approves Illumina's Plan to Unwind Its Completed Acquisition of Grail
Stephens Sticks to Their Buy Rating for Illumina (ILMN)
Illumina Is Maintained at Underweight by Barclays
Illumina Is Maintained at Underweight by Barclays
Express News | Barclays Maintains Underweight on Illumina, Raises Price Target to $100
Analysis
Price Target
No Data
